STRING: 7955.ENSDARP00000006665
UniGene: Dr.81478
Sult1st3, also known as sulfotransferase family 1, cytosolic sulfotransferase 3, is a protein-coding gene in zebrafish (Danio rerio). It was previously identified by the names wu:fj78b11 and zgc:92322 . This enzyme enables sulfotransferase activity and is primarily involved in xenobiotic metabolic processes. Sulfotransferases catalyze the transfer of a sulfonate moiety from the universal sulfate donor 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to various acceptor molecules containing hydroxyl, sulfhydryl, amino, or N-oxide groups .
In zebrafish, sult1st3 is predicted to be active in the cytoplasm, consistent with its classification as a cytosolic sulfotransferase . While specific substrates for sult1st3 have not been fully characterized in the search results, research on related zebrafish sulfotransferases suggests that members of this family may be involved in the metabolism of both endogenous compounds (such as hormones) and xenobiotics (environmental compounds or drugs) .
Sult1st3 in zebrafish is orthologous to human SULT1E1 (sulfotransferase family 1E member 1) . This orthology relationship suggests functional similarity between the zebrafish and human enzymes. Human ortholog(s) of this gene have been implicated in several diseases, including breast cancer and endometrial cancer .
Understanding this evolutionary relationship is crucial for researchers using zebrafish as a model organism for human disease studies. The conservation of sulfotransferase functions across species suggests that zebrafish sult1st3 studies may provide insights relevant to human SULT1E1 function in normal physiology and disease states.
The sult1st3 protein contains specific functional domains that are characteristic of the sulfotransferase family. According to domain analysis, the protein contains a sulfotransferase domain . The protein lengths of known isoforms (UniProtKB:Q7T2V2 and UniProtKB:Q6DHG7) are both 301 amino acids .
Structurally, like other cytosolic sulfotransferases, sult1st3 likely contains a P-loop containing nucleoside triphosphate hydrolase domain, which is important for binding and orientation of the PAPS cofactor during catalysis . These structural features are critical for the enzyme's function in transferring sulfonate groups to various substrates.
While the search results don't provide specific developmental expression data for sult1st3, studies on related zebrafish sulfotransferases provide a methodological framework for such investigations. For example, SULT1 ST9, SULT3 ST4, and SULT3 ST5 have been analyzed using reverse transcription-polymerase chain reaction (RT-PCR) to examine their expression at different developmental stages during embryogenesis, through larval development, and into maturity .
To determine the developmental expression pattern of sult1st3, researchers could employ similar RT-PCR approaches using stage-specific RNA samples from unfertilized eggs, embryos at various developmental timepoints, larvae, and adult fish (both male and female). The specific primer design for sult1st3 would target its unique sequence regions to ensure specificity .
Determining tissue-specific expression of sult1st3 would require a combination of molecular and histological techniques. Based on approaches used for other sulfotransferases, researchers could:
Perform quantitative RT-PCR using RNA isolated from different zebrafish tissues (brain, liver, intestine, gonads, etc.)
Conduct immunohistochemical analysis using antibodies specific to sult1st3
Generate transgenic reporter lines with the sult1st3 promoter driving fluorescent protein expression
While studies on human sulfotransferases have shown distinct expression patterns across different tissues (e.g., SULT1A1 and SULT1A3 in various brain regions) , the tissue-specific expression of sult1st3 in zebrafish would need to be determined experimentally. Understanding this distribution is crucial for interpreting the enzyme's physiological roles.
Based on methodologies used for other zebrafish sulfotransferases, researchers can employ the following approach for cloning and expressing recombinant sult1st3:
Primer Design: Design PCR primers incorporating appropriate restriction sites (e.g., BamHI) based on the sult1st3 sequence .
Template Preparation: Generate first-strand cDNA by reverse transcription using total RNA isolated from zebrafish tissues where sult1st3 is expressed .
PCR Amplification: Perform PCR using high-fidelity DNA polymerase (e.g., Ex Taq DNA polymerase) under optimized conditions similar to: 2 min at 94°C for initial denaturation, followed by 20 cycles of 94°C for 35 sec, 60°C for 40 sec, and 72°C for 1 min .
Cloning Vector Selection: Clone the PCR product into an appropriate expression vector such as pMAL-c5x or pGEX-2T to generate fusion proteins with maltose-binding protein (MBP) or glutathione S-transferase (GST) tags that facilitate purification .
Expression System: Transform competent E. coli BL21(DE3) cells with the recombinant plasmid and induce protein expression with IPTG when the culture reaches approximately 0.6 OD at 600 nm .
For optimal purification of recombinant sult1st3, researchers can implement the following strategy:
Cell Lysis: After IPTG induction, collect cells by centrifugation and homogenize in ice-cold lysis buffer using a French Press or sonication. Add protease inhibitors (e.g., aprotinin) to prevent degradation .
Affinity Chromatography: Based on the fusion tag, purify using:
For MBP-tagged sult1st3: Use amylose resin and elute with maltose in buffer (50 mM Tris-HCl, pH 8.0)
For GST-tagged sult1st3: Use glutathione-Sepharose and either elute with reduced glutathione or cleave the protein directly from the resin using thrombin (in 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 2.5 mM CaCl₂)
Quality Control: Verify protein purity using SDS-PAGE and assess activity using appropriate enzymatic assays .
Storage: Store purified enzyme in buffer containing stabilizers such as DTT (1 mM) with glycerol (10-20%) at -80°C to maintain activity.
This approach has been successful for related zebrafish sulfotransferases and likely would yield active recombinant sult1st3.
To determine the substrate specificity of sult1st3, researchers should employ systematic enzymatic assays testing various potential substrates. Based on approaches used for related sulfotransferases, the following methodology is recommended:
Prepare standardized enzymatic assay mixtures containing:
Test a panel of potential substrates including:
Endogenous compounds: steroid hormones (DHEA, pregnenolone, 17β-estradiol, corticosterone, androstene-3,17-dione), thyroid hormones (T₃, T₄)
Xenobiotics: phenolic compounds (β-naphthol), aromatic amines (β-naphthylamine), plant phenolics (caffeic acid, gallic acid), pharmaceutical compounds (mestranol, 17α-ethynylestradiol)
Analyze reaction products using thin-layer chromatography (TLC) with a solvent system containing n-butanol, isopropanol, 88% formic acid, and H₂O in a ratio of 3:1:1:1 (by volume) .
Quantify sulfated products by autoradiography and scintillation counting .
Based on studies of related sulfotransferases, substrate specificity patterns may emerge - for example, SULT1 family members often show preference for phenolic compounds, while SULT3 family members may exhibit stronger activity toward steroids and other endogenous substrates .
Determining optimal reaction conditions requires systematic testing of various parameters:
pH Optimization:
Temperature Dependence:
Assess activity at temperatures ranging from 25°C to 45°C to determine the temperature optimum
Evaluate thermal stability by pre-incubating the enzyme at various temperatures before assaying activity
Cofactor Requirements:
Determine the optimal concentration of PAPS (typically in the range of 1-20 μM)
Test the effects of divalent cations (Mg²⁺, Mn²⁺, Ca²⁺) and reducing agents (DTT, β-mercaptoethanol)
Kinetic Parameters:
For identified substrates, determine Km and Vmax values under optimal conditions
Calculate catalytic efficiency (kcat/Km) to compare substrate preferences quantitatively
These optimized conditions would be essential for accurate characterization of sult1st3 and comparison with other sulfotransferases.
For robust determination of sult1st3 kinetic parameters, researchers should:
Perform Initial Velocity Studies:
Ensure reactions are measured in the linear range of enzyme activity
Use substrate concentrations spanning at least 0.2-5 times the Km value (typically a range from 0.1 μM to 100 μM for most SULT substrates)
Include proper controls without substrate or enzyme
Data Analysis Methods:
Apply appropriate enzyme kinetic models:
Michaelis-Menten equation for simple kinetics
Hill equation if cooperativity is observed
Competitive, non-competitive, or uncompetitive inhibition models when examining inhibitors
Considerations for Substrate Inhibition:
Many sulfotransferases exhibit substrate inhibition at higher concentrations
Test a wide range of substrate concentrations to detect potential substrate inhibition
Apply modified kinetic equations accounting for substrate inhibition when appropriate
Reporting Standards:
Report Km (μM), Vmax (nmol/min/mg), kcat (min⁻¹), and catalytic efficiency (kcat/Km)
Include standard errors and experimental conditions in all reports
Present results in tabular format for comparison with other SULT enzymes
Example table format for reporting kinetic parameters:
| Substrate | Km (μM) | Vmax (nmol/min/mg) | kcat (min⁻¹) | kcat/Km (min⁻¹μM⁻¹) |
|---|---|---|---|---|
| DHEA | - | - | - | - |
| β-naphthol | - | - | - | - |
| 17β-estradiol | - | - | - | - |
This systematic approach would yield reliable kinetic parameters for comparison with other sulfotransferases.
Modern gene editing approaches offer powerful tools to investigate sult1st3 function in zebrafish:
CRISPR/Cas9 Knockout Strategies:
Design sgRNAs targeting exonic regions of sult1st3
Generate complete knockouts or specific domain mutations
Analyze phenotypic consequences across development
Examine changes in metabolite profiles through targeted metabolomics
Conditional Knockdown Approaches:
Employ morpholino oligonucleotides for transient developmental knockdown
Use inducible promoter systems for temporal control of sult1st3 expression
Create tissue-specific knockout lines using Cre-lox systems
Overexpression and Rescue Studies:
Generate transgenic lines overexpressing wild-type or mutant sult1st3
Perform rescue experiments in knockout backgrounds
Examine dosage effects through titrated expression systems
Phenotypic Analysis:
Compare developmental milestones and morphology
Analyze xenobiotic sensitivity in wild-type versus mutant fish
Assess substrate metabolism through analytical chemistry approaches
Examine gene expression changes through RNA-seq to identify downstream pathways
These approaches would help elucidate the physiological and developmental roles of sult1st3 in zebrafish, potentially providing insights relevant to human SULT1E1 function.
Based on information about related sulfotransferases, sult1st3 likely plays an important role in xenobiotic metabolism. To investigate this role specifically:
Comparative Toxicity Assays:
Expose sult1st3 knockout and wild-type zebrafish to various xenobiotics
Determine LC50 values and time-dependent toxicity profiles
Analyze behavioral responses to sub-lethal toxicant exposure
Metabolite Profiling:
Use liquid chromatography-mass spectrometry (LC-MS) to identify and quantify sulfated metabolites
Compare metabolite profiles between wild-type and sult1st3-deficient fish
Trace the fate of labeled xenobiotics to identify sult1st3-dependent metabolic pathways
Cellular Localization Studies:
Examine tissue-specific expression patterns in response to xenobiotic exposure
Determine subcellular localization through fractionation and immunohistochemistry
Analyze potential translocation or expression changes upon toxicant exposure
Pathway Interaction Analysis:
Investigate potential interactions with other detoxification enzymes (cytochrome P450s, UDP-glucuronosyltransferases)
Examine compensatory changes in other SULT family members in sult1st3 knockouts
Identify potential synergistic or antagonistic relationships with other detoxification pathways
Since xenobiotic metabolism is a key function of sulfotransferases, understanding sult1st3's specific role would have implications for environmental toxicology and pharmacology research.
Given that human SULT1E1 (ortholog of zebrafish sult1st3) is known to be involved in estrogen metabolism, sult1st3 may play a role in hormone signaling in zebrafish. To investigate this:
Hormone Metabolism Assays:
Test sult1st3 activity toward various steroid hormones in vitro
Quantify sulfated hormone metabolites in wild-type versus sult1st3 knockout fish
Examine hormone-dependent developmental processes in mutant versus wild-type fish
Reproductive and Developmental Effects:
Analyze gonadal development in sult1st3-deficient fish
Assess fertility, fecundity, and reproductive behaviors
Examine sexually dimorphic traits and secondary sex characteristics
Endocrine Disruption Sensitivity:
Test sensitivity to endocrine-disrupting chemicals in wild-type versus sult1st3 knockout fish
Examine potential protective effects of sult1st3 against estrogen-mimicking compounds
Investigate potential biomarker applications for environmental estrogen exposure
Gene Expression Analysis:
Perform transcriptome analysis of hormone-responsive tissues in wild-type versus mutant fish
Examine expression changes in hormone receptor genes and hormone-responsive genes
Investigate feedback mechanisms between hormone levels and sult1st3 expression
Understanding the role of sult1st3 in hormone metabolism could provide insights into endocrine regulation and potential implications for reproductive and developmental biology.
Advanced structural biology techniques can provide detailed insights into sult1st3 function:
Protein Crystallography:
Express, purify, and crystallize recombinant sult1st3
Determine high-resolution crystal structures of apo-enzyme and enzyme-substrate complexes
Identify key catalytic residues and substrate binding sites
Compare structural features with human SULT1E1 to understand evolutionary conservation
Molecular Dynamics Simulations:
Model substrate binding and catalytic mechanisms
Simulate conformational changes during catalysis
Predict effects of mutations on protein stability and function
Investigate water networks and proton transfer pathways
Structure-Based Drug Design:
Use structural information to design selective inhibitors or substrate analogs
Develop tools to modulate sult1st3 activity in vivo
Create structure-activity relationship (SAR) models for substrate specificity
Site-Directed Mutagenesis Validation:
Design mutations of predicted key residues based on structural data
Express and characterize mutant proteins to validate structural hypotheses
Correlate structure-function relationships through activity assays
These approaches would provide molecular-level understanding of sult1st3 catalysis and substrate recognition, potentially enabling applications in drug development and toxicology.
Investigating polymorphisms in sult1st3 could reveal important insights into natural variation and functional consequences:
Population Genetics Approaches:
Sequence sult1st3 from diverse wild zebrafish populations
Identify common variants and their frequencies
Examine evidence for selective pressures through population genetic analyses
Functional Characterization of Variants:
Express and purify variant forms of sult1st3
Compare enzymatic activities and substrate specificities
Analyze thermal stability and other biophysical properties
Phenotypic Consequences:
Generate zebrafish lines expressing different natural variants
Compare xenobiotic sensitivity and metabolism
Examine potential differences in hormone regulation and developmental processes
Comparative Analysis with Human SULT1E1 Polymorphisms:
Relate zebrafish sult1st3 variants to known human SULT1E1 polymorphisms
Assess potential as a model for human variation
Examine conservation of functionally significant variants
This research area could provide insights into natural adaptation mechanisms and potentially model human polymorphism effects seen in SULT1E1, where variations have been linked to altered drug metabolism and potentially disease risk .
Systems biology offers tools to understand sult1st3 in the context of broader biological networks:
Multi-Omics Integration:
Combine transcriptomics, proteomics, and metabolomics data from wild-type and sult1st3 knockout fish
Identify metabolic pathways affected by sult1st3 deficiency
Construct network models of sult1st3-dependent processes
Pathway Analysis:
Map sult1st3 substrates and products onto known metabolic pathways
Identify regulatory interactions with other detoxification systems
Examine potential feedback mechanisms and compensatory responses
Mathematical Modeling:
Develop kinetic models of sult1st3-dependent metabolic pathways
Simulate effects of altered enzyme activity on metabolite concentrations
Predict emergent system properties through in silico experiments
Physiological Integration:
Connect molecular-level findings to tissue, organ, and whole-organism phenotypes
Investigate developmental stage-specific roles in different tissues
Examine potential interactions with environmental factors
As sult1st3 is orthologous to human SULT1E1, research in zebrafish can provide valuable insights for human applications:
Comparative Functional Analysis:
Systematically compare substrate specificities between zebrafish sult1st3 and human SULT1E1
Identify conserved regulatory mechanisms and expression patterns
Assess conservation of protein-protein interactions and metabolic pathways
Disease Modeling:
Create zebrafish models mimicking human SULT1E1 mutations associated with disease
Investigate developmental and physiological consequences
Test potential therapeutic interventions in zebrafish before moving to mammalian models
Drug Metabolism Studies:
Use zebrafish as a model to predict human drug metabolism patterns
Investigate the role of SULT1E1/sult1st3 in metabolizing therapeutic compounds
Examine potential drug-drug interactions mediated by sulfotransferase activity
Environmental Toxicology Applications:
Develop zebrafish-based assays for environmental toxicants affecting sulfotransferase activity
Validate findings through comparative studies with human cells and tissues
Create biomarkers for xenobiotic exposure relevant to human health
Given that human SULT1E1 has been implicated in breast cancer and endometrial cancer , understanding the fundamental biology of its zebrafish ortholog could potentially contribute to cancer research and therapeutic development.
Researchers face several challenges when working with recombinant sulfotransferases, including:
Protein Solubility and Stability Issues:
Assay Sensitivity and Specificity:
Substrate Availability and Handling:
Challenge: Many potential substrates have poor solubility or stability
Solution: Develop appropriate solubilization methods (use of compatible co-solvents like DMSO at <1% final concentration), prepare fresh substrate solutions, and establish stability profiles
Interpretation of Kinetic Data:
Challenge: Complex kinetic behaviors including substrate inhibition
Solution: Use appropriate kinetic models, test wide concentration ranges, and employ global data fitting approaches for complex mechanisms
These methodological considerations are crucial for generating reliable data on sult1st3 function and comparing results across different studies.
Several cutting-edge technologies hold promise for advancing sult1st3 research:
CRISPR-Based Approaches:
Base editing for introducing specific point mutations
Prime editing for precise genomic modifications
CRISPRi/CRISPRa for temporally controlled gene expression modulation
CRISPR screening to identify genetic interactions
Advanced Imaging Techniques:
Live cell imaging of fluorescently tagged sult1st3
Super-resolution microscopy to examine subcellular localization
Correlative light and electron microscopy (CLEM) for structural context
Whole-organism imaging of substrate metabolism in transparent zebrafish larvae
Single-Cell Technologies:
Single-cell RNA-seq to examine cell-type specific expression patterns
Spatial transcriptomics to map expression in tissue context
Single-cell proteomics to examine protein-level regulation
Integration of multi-modal single-cell data for comprehensive understanding
Computational Approaches:
Machine learning for substrate prediction
Quantum mechanics/molecular mechanics (QM/MM) simulations of reaction mechanisms
Network pharmacology to predict drug interactions
Virtual screening for novel substrates or inhibitors
These technologies could overcome current limitations and provide unprecedented insights into sult1st3 biology and function.
Researchers sometimes encounter contradictory results in sulfotransferase studies. Strategies to address these include:
Standardization of Experimental Protocols:
Develop consensus methods for expression, purification, and activity assays
Create standard reference materials (purified enzymes, substrate sets)
Establish reporting standards for experimental conditions and kinetic parameters
Systematic Meta-Analysis:
Compare methodologies across contradictory studies
Identify variables that might explain discrepancies (pH, temperature, buffer composition)
Re-analyze raw data when available using consistent analytical approaches
Collaborative Validation Studies:
Conduct multi-laboratory validation studies
Test identical enzyme preparations across different assay platforms
Develop proficiency testing programs for sulfotransferase assays
Consideration of Biological Variables:
Investigate effects of post-translational modifications
Examine contextual factors (presence of cofactors, inhibitors)
Consider developmental and physiological state differences
Account for genetic background effects in in vivo studies
Through these approaches, apparent contradictions may be resolved, leading to more robust and reproducible findings in the field.